Clonidine Use in Older Adults

Primary Recommendation

The European Society of Cardiology recommends that central-acting antihypertensive drugs like clonidine are not used unless there is intolerance or lack of efficacy of other antihypertensives, due to risks of depression, bradycardia, and orthostatic hypotension in older adults 1, 2, 3
The American College of Cardiology reserves clonidine as a last-line option due to significant CNS adverse effects, particularly in older adults 4

First-line agents for hypertension treatment include ACE inhibitors/ARBs, calcium channel blockers, and thiazide diuretics, according to the European Society of Cardiology 4, 5
Second-line treatment for resistant hypertension may include spironolactone if renal function and potassium levels permit, as recommended by the American College of Cardiology 6
Clonidine should only be considered as a third-line option if spironolactone is contraindicated or not tolerated, due to its potential for adverse effects in older adults 4, 5, 6

Older adults, such as those aged 71, are at heightened risk of orthostatic hypotension, CNS effects, depression, and bradycardia when taking clonidine, according to the European Society of Cardiology 1, 2, 3
The European Society of Cardiology warns that clonidine may precipitate or exacerbate depression, bradycardia, and orthostatic hypotension in older adults 1, 2, 3

If clonidine is necessary, strict monitoring protocols are mandatory, including holding the medication if systolic BP is <90 mmHg, diastolic BP is <60 mmHg, or heart rate is <50 bpm, as recommended by the American College of Cardiology 4
Gradual tapering of clonidine is essential to prevent severe rebound hypertensive crisis, according to the American College of Cardiology 4, 5, 6

Monthly follow-up is required until BP control is achieved, with a target BP of <130/80 mmHg for patients with confirmed CVD or 10-year ASCVD risk ≥10%, as recommended by the American College of Cardiology 4

Abrupt discontinuation of clonidine can induce severe hypertensive crisis, and clonidine should not be used in patients with a history of depression, baseline bradycardia or heart block, poor mobility or fall risk, or cognitive impairment, according to the European Society of Cardiology and the American College of Cardiology 1, 2, 3, 4, 6

Without a diagnosis of hypertension (BP ≥140/90 mmHg confirmed by home or ambulatory monitoring showing ≥135/85 mmHg or ≥130/80 mmHg respectively), there is no therapeutic target for clonidine to address, as noted in a study published in 2020 7

No specific facts with citations were found in this section, however the previous fact is relevant to understanding the risks. 7